ACRV

Acrivon Therapeutics, Inc.

Sales chart range
Log in to watch ACRV
Latest sale
$155
Nov 17 · No plan
Form 4 sales
18
On record
Form 144 notices
1
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

0
Routine
0
Plan not stated
6
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. 1 Form 4 saleNo plan
    Aug 18 2026

    Sold 185 shares at $2.01 ($372)

    Miller Mary, Chief Legal Officer

    No 10b5-1 planSold 0.2% of holdings ($165k position)82,009 shares leftFiling

  2. 2 Form 4 saleNo plan
    Aug 18 same day

    Sold 101 shares at $2.01 ($203)

    Peterson Katharine, Chief Accounting Officer

    No 10b5-1 planSold 0.6% of holdings ($36k position)18,033 shares leftFirst sale on recordFiling

  3. 3 Form 4 saleNo plan
    Aug 25 +7 days

    Sold 14,036 shares at $2.21 ($31k)

    Blume-Jensen Peter, President and CEO

    No 10b5-1 planSold 0.6% of holdings ($5M position)2.2M shares leftFirst sale on recordFiling

  4. 4 Form 4 saleNo plan
    Nov 17 +84 days

    Sold 1,780 shares at $1.45 ($3k)

    Blume-Jensen Peter, President and CEO

    No 10b5-1 planSold 0.1% of holdings ($3.2M position)2.2M shares leftFiling

  5. 5 Form 4 saleNo plan
    Nov 17 same day

    Sold 628 shares at $1.45 ($911)

    Devroe Eric, Chief Operating Officer

    No 10b5-1 planSold 0.4% of holdings ($212k position)145,721 shares leftFiling

  6. 6 Form 4 saleNo plan
    Nov 17 same day

    Sold 416 shares at $1.45 ($603)

    Gamelin Erick, Chief Development Officer

    No 10b5-1 planSold 0.8% of holdings ($76k position)52,176 shares leftFiling

  7. 7 Form 4 saleNo plan
    Nov 17 same day

    Sold 193 shares at $1.45 ($280)

    Miller Mary, Chief Legal Officer

    No 10b5-1 planSold 0.2% of holdings ($118k position)81,009 shares leftFiling

  8. 8 Form 4 saleNo plan
    Nov 17 same day

    Sold 107 shares at $1.45 ($155)

    Peterson Katharine, Chief Accounting Officer

    No 10b5-1 planSold 0.6% of holdings ($26k position)17,926 shares leftFiling

Every transaction

Loading transactions…

Sales, notices and lockups (19)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for ACRV
Source
Nov 17, 2026Peterson KatharineChief Accounting OfficerForm 4 sale107$1550.6%No planSEC
Nov 17, 2026Miller MaryChief Legal OfficerForm 4 sale193$2800.2%No planSEC
Nov 17, 2026Gamelin ErickChief Development OfficerForm 4 sale416$6030.8%No planSEC
Nov 17, 2026Devroe EricChief Operating OfficerForm 4 sale628$9110.4%No planSEC
Nov 17, 2026Blume-Jensen PeterPresident and CEOForm 4 sale1,780$3k0.1%No planSEC
Aug 25, 2026Blume-Jensen PeterPresident and CEOForm 4 sale14,036$31k0.6%No planSEC
Aug 18, 2026Peterson KatharineChief Accounting OfficerForm 4 sale101$2030.6%No planSEC
Aug 18, 2026Miller MaryChief Legal OfficerForm 4 sale185$3720.2%No planSEC
Aug 18, 2026Gamelin ErickChief Development OfficerForm 4 sale400$8040.8%No planSEC
Aug 18, 2026Devroe EricChief Operating OfficerForm 4 sale604$1k0.4%No planSEC
Aug 18, 2026Masson KristinaEVP - Business OperationsForm 4 sale1,713$3k0.1%No planSEC
Aug 4, 2026Levy Adam D.Chief Financial OfficerForm 4 sale1,142$2k1.7%No planSEC
Jul 21, 2026Miller MaryChief Legal OfficerForm 4 sale573$1k0.7%No planSEC
May 1, 2025Perceptive Advisors LLC10% ownerForm 4 sale736,767$1M19.2%No planSEC
Apr 29, 2025Perceptive Advisors LLC10% ownerForm 4 sale1.5M$2.7M28.4%UnusualSEC
Jun 26, 2023Smolokowski Wiaczeslaw10% ownerForm 4 sale16$2070.0%No planSEC
Jun 15, 2023Nikolaou Anastasis10% ownerForm 4 sale2,056$25k0.1%No planSEC
Jun 14, 2023Chione Ltd10% ownerForm 4 sale5,893$72k0.2%No planSEC
Jun 12, 2023Chione Ltd10% StockholderForm 144 notice219,259$2.7MNoticeSEC